Interleukin 10 (IL-10) Inhibits Human Lymphocyte Interferon 3,-Production by Suppressing Natural Killer Cell Stimulatory Factor/IL-12 Synthesis in Accessory Cells By Annalisa D'Andrea, Miguel Aste-Amezaga,
Interleukin 10 (IL-10) Inhibits Human Lymphocyte Interferon 3,-Production by Suppressing Natural Killer Cell Stimulatory Factor/IL-12 Synthesis in Accessory Cells By Annalisa D'Andrea, Miguel Aste-Amezaga,
复制标题
DOI:
--
复制
发表时间:
1993
期刊:
影响因子:
--
通讯作者:
N. Valiante;Xiaojing Ma;M. Kubin;G. Trinchieri
中科院分区:
文献类型:
--
作者:
N. Valiante;Xiaojing Ma;M. Kubin;G. Trinchieri
SulTlnlary Natural killer cell stimulatory factor or interleukin 12 (NKSF/IL-12) is a heterodimeric cytokine produced by monocytes/macrophages, B cells, and possibly other accessory cell types primarily in response to bacteria or bacterial products. NKSF/IL-12 mediates pleiomorphic biological activity on T and NK cells and, alone or in synergy with other inducers, is a powerful stimulator of interferon 3' (IFN-3") production. IL-10 is a potent inhibitor of monocyte-macrophage activation, that inhibits production of tumor necrosis factor ot (TNF-o 0, IL-1 and also IFN-3' from lymphocytes acting at the level of accessory cells. Because TNF-ot and IL-1 are not efficient inducers of IFN-3', the mechanism by which IL-10 inhibits IFN-3' production is not clear. In this paper, we show that IL-IO is a potent inhibitor of NKSF/IL-12 production from human peripheral blood mononuclear cells activated with Staphylococcus aureus or lipopolysaccharide (LPS). Both the production of the free NKSF/IL-12 p40 chain and the biologically active p70 heterodimer are blocked by IL-10. NKSF/IL-12 p40 chain mRNA accumulation is strongly induced by S. aureus or LPS and downregulated by IL-10, whereas the p35 mRNA is constitutively expressed and only minimally regulated by S. aureus, LPS, or IL-10. Although IL-IO is able to block the production of NKSF/IL-12, a powerful inducer of IFN-3' both in vitro and in vivo, the mechanism of inhibition of IFN-3' by IL-10 cannot be explained only on the basis of inhibition of NKSF/IL-12 because IL-10 can partially inhibit IFN-3' production induced by NKSF/IL-12, and also, the IFN-3' production in response to various stimuli in the presence of neutralizing antibodies to NKSF/IL12. Our findings that antibodies against NKSF/IL-12, TNF-o~, or IL-1~ can significantly inhibit IFN-3" production in response to various stimuli and that NKSF/IL-12 and IL-1B can overcome the IL-10-mediated inhibition of IFN-% suggest that IL-10 inhibition of IFN-3' production is primarily due to its blocking production from accessory cells of the IFN-3'-inducer NKSF/IL12, as well as the costimulating molecule IL-1/~.